Original Literature | Model OverView |
---|---|
Publication
Title
Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signalingcascades during intracellular Toxoplasma gondii infection.
Affiliation
Department of Microbiology and Immunology, College of Veterinary Medicine,Cornell University, Ithaca, NY, USA. eyd1@cornell.edu
Abstract
The intracellular protozoan Toxoplasma gondii exerts profound effects on nuclearfactor-kappaB (NF-kappaB)- and mitogen-activated protein kinase (MAPK)-signalingcascades in macrophages. During early infection, nuclear translocation ofNF-kappaB is blocked, and later, the cells display defects in lipopolysaccharide(LPS)-induced MAPK phosphorylation after undergoing initial activation inresponse to Toxoplasma itself. Infected macrophages that are subjected totriggering through Toll-like receptor 4 (TLR4) with LPS display defectiveproduction of tumor necrosis factor-alpha and IL-12 (IL-12) that likely reflectsinterference with NF-kappaB- and MAPK-signaling cascades. Nevertheless, T.gondii possesses molecules that themselves induce eventual proinflammatorycytokine synthesis. For interleukin-12, this occurs through both myeloiddifferentiation factor 88-dependent and chemokine receptor CCR5-dependentpathways. The balance between activation and interference with proinflammatorysignaling is likely to reflect the need to achieve an appropriate level ofimmunity that allows the host and parasite to maintain a stable interaction.
PMID
15361242
|
Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
Ligand:TLR
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
MYD88
--
e12
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m12
0
infinite
0
--
Ligand:TLR:MYD88
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
IRAK1:IRAK4
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
Ligand:TLR:MYD88:IRAK1:IRAK4
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
TRAF6
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
Ligand:TLR:MYD88:IRAK1:IRAK4:TRAF6
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
IRAK1:IRAK4:TRAF6
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TAK1:TAB1:TAB2
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m20
0
infinite
0
--
IRAK1:IRAK4:TRAF6:TAK1:TAB1:TAB2
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m21
0
infinite
0
--
TRAF6:TAK1:TAB1:TAB2
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
IKKalpha:IKKbeta:IKKgamma
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
IKKalpha:IKKbeta:IKKgamma {active}
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
IkappaB-NFkappaB
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
IkappaB{active}:NFkappaB
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
protein remnants
--
e27
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
NF-kappaB
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
NF-kappaB
--
e29
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IkappaB{ub}:NF-kappaB
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
IkappaB
--
e31
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m31
0
infinite
0
--
IkappaB
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
IkappaB
--
e33
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m33
0
infinite
0
--
IkappaB:NF-kappaB
--
e34
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m34
0
infinite
0
--
MKK
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
MKK{p}
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
JNK
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
JNK{p}
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
p38
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
p38{p}
--
e40
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
ERK1
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
ERK1{p}
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
ERK2
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
ERK2{p]
--
e44
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
ATF2
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
ATF2{active}
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
csml-variable:Double
m48
0
infinite
0
--
CREB{active}
--
e49
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
Microbial ligand
--
e5
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TLR
--
e6
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
ELK1
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
ELK1{active}
--
e65
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
c-jun
--
e66
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
c-jun{active}
--
e67
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
NFIL6
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
NFIL6{active}
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
TNF-alpha
--
e70
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m70
0
infinite
0
--
iNOS
--
e71
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m71
0
infinite
0
--
NOS2
--
e72
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m72
0
infinite
0
--
IL-12-p40
--
e73
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m73
0
infinite
0
--
gondii cell
--
e74
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m74
0
infinite
0
--
IFN-gmma
--
e75
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m75
0
infinite
0
--
IFN-gammaR
--
e76
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m76
0
infinite
0
--
IFN-gamma:IFNgammaR
--
e77
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m77
0
infinite
0
--
Stat1
--
e78
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m78
0
infinite
0
--
Stat1{p}
--
e79
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
Stat1{p}
--
e80
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m80
0
infinite
0
--
mucin
--
e81
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m81
0
infinite
0
--
PP2Ac
--
e84
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
okadic acid
--
e87
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
lipophosphoglycan
--
e88
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m88
0
infinite
0
--
TLR2
--
e89
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m89
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
Lipophosphoglycan:TLR2
--
e90
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m90
0
infinite
0
--
SHP1
--
e91
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m91
0
infinite
0
--
SHP1{active}
--
e92
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
csml-variable:Double
m93
0
infinite
0
--
JAK2{active}
--
e94
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m94
0
infinite
0
--
C-18
--
e95
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m95
0
infinite
0
--
CCR5
--
e96
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m96
0
infinite
0
--
C-18:CCR5
--
e97
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m97
0
infinite
0
--
IL20
--
e98
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m98
0
infinite
0
--
pertussis toxin
--
e99
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m99
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m6*m5*0.1
nodelay
--
0
PMID: 15361242 The TLR family recognizes an increasingly diverse spectrum of microbial ligands.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c33 : 1
m26*0.1
nodelay
--
0
PMID: 15361242 When IkB molecules, most prominently IkBalpha, undergo phosphorylative activation, they are targeted for ubiquitin-dependent proteasomal degradation as a result of the activity of IkB-targeted ubiquitin ligases.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c132 : 1
stoichiometry:c31 : 1
m28*0.1
nodelay
--
0
PMID: 15361242, 11490005 Degradation of IkB reveals NF-kB nuclear localization sequences, and the latter molecule undergoes nuclear translocation. 2 h gondii pre-infected cells fail to undergo NF-kB translocation when subjected to LPS triggering via TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c32 : 1
m30*0.1
nodelay
--
0
PMID: 15361242, 11490005 When IkB molecules, most prominently IkBalpha, undergo phosphorylative activation, they are targeted for ubiquitin-dependent proteasomal degradation as a result of the activity of IkB-targeted ubiquitin ligases.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m29*0.1
nodelay
--
0
PMID: 15361242 Genes whose promoters contain kB-binding sites are then targeted for transcriptional activation. One such NF-kB regulated gene is that encoding IkB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m31*0.1
nodelay
--
0
PMID: 15361242, 8278379 Newly synthesized IkB translocates to the nucleus and binds NF-kB, terminating its activity and mediating nuclear export of the complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m32*0.1
nodelay
--
0
PMID: 15361242, 8278379 Newly synthesized IkB translocates to the nucleus and binds NF-kB, terminating its activity and mediating nuclear export of the complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m29*m33*0.1
nodelay
--
0
PMID: 15361242, 8278379 Newly synthesized IkB translocates to the nucleus and binds NF-kB, terminating its activity and mediating nuclear export of the complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m34*0.1
nodelay
--
0
PMID: 15361242, 8278379 Newly synthesized IkB translocates to the nucleus and binds NF-kB, terminating its activity and mediating nuclear export of the complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c47 : 1
stoichiometry:c46 : 1
m35*m22*0.1
nodelay
--
0
PMID: 15361242 MAPKs are activated by phosphorylation of Thr-X-Tyr tripeptide motifs mediated by upstream MAPK kinases (MKKs). The MKKs in turn are activated by MKK kinases (M3Ks), a prominent one of which is TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c50 : 1
stoichiometry:c49 : 1
m37*m36*0.1
nodelay
--
0
PMID: 15361242 MAPKs are activated by phosphorylation of Thr-X-Tyr tripeptide motifs mediated by upstream MAPK kinases (MKKs). The MKKs in turn are activated by MKK kinases (M3Ks), a prominent one of which is TAK1. purifed Leishmania lipophosphoglycan activates MAPK family members in a TLR2-dependent cascade
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m11*m12*0.1
nodelay
--
0
PMID: 15361242 The TLR family recognizes an increasingly diverse spectrum of microbial ligands, resulting in recruitment of the adapter molecule myeloid differentiation factor 88 (MyD88).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c53 : 1
stoichiometry:c52 : 1
m39*m36*0.1
nodelay
--
0
PMID: 15361242 MAPKs are activated by phosphorylation of Thr-X-Tyr tripeptide motifs mediated by upstream MAPK kinases (MKKs). The MKKs in turn are activated by MKK kinases (M3Ks), a prominent one of which is TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c56 : 1
stoichiometry:c55 : 1
m41*m36*0.1
nodelay
--
0
PMID: 15361242 MAPKs are activated by phosphorylation of Thr-X-Tyr tripeptide motifs mediated by upstream MAPK kinases (MKKs). The MKKs in turn are activated by MKK kinases (M3Ks), a prominent one of which is TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m43*m36*0.1
nodelay
--
0
PMID: 15361242 MAPKs are activated by phosphorylation of Thr-X-Tyr tripeptide motifs mediated by upstream MAPK kinases (MKKs). The MKKs in turn are activated by MKK kinases (M3Ks), a prominent one of which is TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c62 : 1
stoichiometry:c61 : 1
m45*m38*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c65 : 1
stoichiometry:c64 : 1
m45*m40*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c68 : 1
stoichiometry:c67 : 1
m45*m42*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c71 : 1
stoichiometry:c70 : 1
m45*m44*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c76 : 1
stoichiometry:c75 : 1
m48*m38*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c79 : 1
stoichiometry:c78 : 1
m48*m40*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m13*m14*0.1
nodelay
--
0
PMID: 15361242, 12620219, 11923871 Formation of TLR:MYD88 complex in turn leads to association with IL-1 receptor-associated kinases-1 (IRAK-1) and IRAK-4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c82 : 1
stoichiometry:c81 : 1
m48*m44*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c85 : 1
stoichiometry:c84 : 1
m48*m42*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c90 : 1
stoichiometry:c89 : 1
m64*m42*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c93 : 1
stoichiometry:c92 : 1
m64*m44*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c96 : 1
stoichiometry:c95 : 1
m64*m40*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c99 : 1
stoichiometry:c98 : 1
m64*m38*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c102 : 1
stoichiometry:c101 : 1
m66*m38*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c105 : 1
stoichiometry:c104 : 1
m66*m40*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c108 : 1
stoichiometry:c107 : 1
m66*m42*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m15*m16*0.1
nodelay
--
0
PMID: 15361242 Activation of the IRAK molecules results in recruitment of TNF receptor-associated factor-6 (TRAF-6).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c111 : 1
stoichiometry:c110 : 1
m66*m44*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c114 : 1
stoichiometry:c113 : 1
m68*m42*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c117 : 1
stoichiometry:c116 : 1
m68*m44*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c120 : 1
stoichiometry:c119 : 1
m68*m40*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c123 : 1
stoichiometry:c122 : 1
m68*m38*0.1
nodelay
--
0
PMID: 15361242 Upon activation, MAPKs themselves activate transcription factors including NF-IL-6, Elk-1, activating transcription factor-2 (ATF-2), cyclic adenosine monophosphate-responsive element-binding protein (CREB), and c-Jun.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
m29*0.1
nodelay
--
0
PMID: 15361242 NF-kappaB induced genes include IL-12(p40), TNF-a and iNOS, and NOS2 genes. parasite in a dose-dependent blockade endotoxin-induced IL-12(p40) and TNF-a production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m29*0.1
nodelay
--
0
PMID: 15361242 NF-kappaB induced genes include IL-12(p40), TNF-a and iNOS, and NOS2 genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
m29*0.1
nodelay
--
0
PMID: 15361242 NF-kappaB induced genes include IL-12(p40), TNF-a and iNOS, and NOS2 genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
m29*0.1
nodelay
--
0
PMID: 15361242, 9104813 NF-kappaB induced genes include IL-12(p40), TNF-a and iNOS, and NOS2, genes whose products play an important role in resistance.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c137 : 1
stoichiometry:c138 : 1
m75*m76*0.1
nodelay
--
0
PMID: 15361242 T. gondii infection blocks the ability of IFN-g to activate signal transducer and activator of transcription 1 (Stat1).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c15 : 1
stoichiometry:c14 : 1
m17*0.1
nodelay
--
0
PMID: 15361242, 12893815 Activation of the IRAK molecules results in recruitment of TNF receptor-associated factor-6 (TRAF-6), leading to dissociation of the IRAK-1/IRAK-4/TRAF-6 from the receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c145 : 1
stoichiometry:c144 : 1
m79*0.1
nodelay
--
0
PMID: 15361242,11465104 Stat1 undergoes phosphorylative activation but fails to translocate into nuclei of infected cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c153 : 1
stoichiometry:c158 : 1
stoichiometry:c155 : 1
m36*m84*0.1
nodelay
--
0
PMID: 15361242, 9707433 The MKKs are also subject to deactivation by phosphatases such as serine/ threonine protein phosphatase type-2Ca that inhibits p38 and SAPK/JNK MAPK by dephosphorylating MKK6, MKK4, and p38 MAPK itself. Inhibition of a protein phosphatase Type-2A with okadaic acid reversed tGPI-mucin-induced hyporesponsiveness allowing MAPK activation and TNF-a production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c157 : 1
stoichiometry:c159 : 1
stoichiometry:c152 : 1
m40*m84*0.1
nodelay
--
0
PMID: 15361242, 9707433 The MKKs are also subject to deactivation by phosphatases such as serine/ threonine protein phosphatase type-2Ca that inhibits p38 and SAPK/JNK MAPK by dephosphorylating MKK6, MKK4, and p38 MAPK itself.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c161 : 1
stoichiometry:c162 : 1
m88*m89*0.1
nodelay
--
0
PMID: 15361242 purifed Leishmania lipophosphoglycan activates MAPK family members in a TLR2-dependent cascade.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c168 : 1
stoichiometry:c167 : 1
m39*m81*0.1
nodelay
--
0
PMID:15361242 Similar MAPK activation is observed using Trypanosoma cruzi glycosylphosphatidylinositol-anchored mucin-like glycoproteins (tGPI-mucin).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c170 : 1
stoichiometry:c169 : 1
m39*m90*0.1
nodelay
--
0
PMID: 15361242 purifed Leishmania lipophosphoglycan activates MAPK family members in a TLR2-dependent cascade
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c172 : 1
stoichiometry:c171 : 1
m37*m81*0.1
nodelay
--
0
PMID: 15361242 Similar MAPK activation is observed using Trypanosoma cruzi glycosylphosphatidylinositol-anchored mucin-like glycoproteins (tGPI-mucin).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c174 : 1
stoichiometry:c173 : 1
m37*m90*0.1
nodelay
--
0
PMID: 15361242 purifed Leishmania lipophosphoglycan activates MAPK family members in a TLR2-dependent cascade
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c176 : 1
stoichiometry:c175 : 1
m43*m81*0.1
nodelay
--
0
PMID: 15361242 Similar MAPK activation is observed using Trypanosoma cruzi glycosylphosphatidylinositol-anchored mucin-like glycoproteins (tGPI-mucin).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m19*m20*0.1
nodelay
--
0
PMID: 15361242 IRAK-1/IRAK-4/TRAF-6 interacts at the membrane with another complex consisting of MAP3K transforming growth factor-b-activated kinase1 (TAK1) and adapter molecules TAK1-binding protein 1 (TAB1) and TAB2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c165 : 1
stoichiometry:c178 : 1
m43*m90*0.1
nodelay
--
0
PMID: 15361242 purifed Leishmania lipophosphoglycan activates MAPK family members in a TLR2-dependent cascade
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c180 : 1
stoichiometry:c179 : 1
m41*m90*0.1
nodelay
--
0
PMID: 15361242 purifed Leishmania lipophosphoglycan activates MAPK family members in a TLR2-dependent cascade
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c183 : 1
stoichiometry:c182 : 1
m41*m81*0.1
nodelay
--
0
PMID: 15361242 Similar MAPK activation is observed using Trypanosoma cruzi glycosylphosphatidylinositol-anchored mucin-like glycoproteins (tGPI-mucin).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c188 : 1
stoichiometry:c187 : 1
m91*m90*0.1
nodelay
--
0
PMID: 15361242, 10556830 Leishmania infection is associated with increased Src homology- 2 domain-containing phosphatase-1 (SHP-1) protein tyrosine phosphatase activity that results in impaired IFN-g-triggered Janus kinase-2 (JAK-2) activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c185 : 1
stoichiometry:c206 : 1
stoichiometry:c184 : 1
m78*m77*0.1
nodelay
--
0
PMID: 15361242 T. gondii infection blocks the ability of IFN-g to activate signal transducer and activator of transcription 1 (Stat1).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c191 : 1
stoichiometry:c190 : 1
m93*m77*0.1
nodelay
--
0
PMID: 15361242, 10556830 Leishmania infection is associated with increased Src homology- 2 domain-containing phosphatase-1 (SHP-1) protein tyrosine phosphatase activity that results in impaired IFN-g-triggered Janus kinase-2 (JAK-2) activation.
p66
p66
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c194 : 1
stoichiometry:c193 : 1
m93*0.1
nodelay
--
0
PMID: 15361242, 10556830 Leishmania infection is associated with increased Src homology- 2 domain-containing phosphatase-1 (SHP-1) protein tyrosine phosphatase activity that results in impaired IFN-g-triggered Janus kinase-2 (JAK-2) activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c196 : 1
stoichiometry:c197 : 1
m95*m96*0.1
nodelay
--
0
PMID: 15361242 The C-18 protein has been shown to trigger dendritic cell IL-12 production in a manner dependent upon binding to chemokine receptor CCR5.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c139 : 1
stoichiometry:c198 : 1
m97*0.1
nodelay
--
0
PMID: 15361242 The C-18 protein has been shown to trigger dendritic cell IL-12 production in a manner dependent upon binding to chemokine receptor CCR5. Chemokine receptors are seven transmembrane domain molecules that signal through G-protein-dependent pathways, and the ability of pertussis toxin, a G-protein uncoupler, to antagonize the IL-12- inducing effects of C-18 implicates this signaling cascade in parasite-driven cytokine production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m21*0.1
nodelay
--
0
PMID: 15361242 The complex TRAF-6/TAK1/TAB1/TAB2 translocates to the cytoplasm.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c134 : 1
1.0*0.1
nodelay
--
0
PMID: 15361242, 9104813 In such cells, there is also a parasite in a dose-dependent blockade endotoxin-induced IL-12(p40) and TNF-a production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c133 : 1
1.0*0.1
nodelay
--
0
PMID: 15361242, 9104813 In such cells, there is also a parasite in a dose-dependent blockade endotoxin-induced IL-12(p40) and TNF-a production
p12
p72
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c205 : 1
stoichiometry:c204 : 1
stoichiometry:c135 : 1
m30*m74*0.1
nodelay
--
0
PMID: 15361242, 11490005 T. gondii efficiently triggers phosphorylative degradation of cytoplasmic IkB, despite a failure to accumulate NF-kB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c23 : 1
stoichiometry:c22 : 1
m23*m22*0.1
nodelay
--
0
PMID: 15361242 Subsequent activation of TAK1, a MAP3K family member, leads to IKK activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c26 : 1
stoichiometry:c25 : 1
m25*m24*0.1
nodelay
--
0
PMID: 15361242 IkB molecules, most prominently IkBalpha, undergo phosphorylative activation.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--